Invesco’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$438M Buy
1,341,694
+427,902
+47% +$140M 0.07% 334
2025
Q1
$247M Buy
913,792
+355,302
+64% +$95.9M 0.05% 517
2024
Q4
$131M Sell
558,490
-137,378
-20% -$32.3M 0.02% 732
2024
Q3
$191M Buy
695,868
+303,027
+77% +$83.3M 0.04% 614
2024
Q2
$95.5M Buy
392,841
+214,528
+120% +$52.1M 0.02% 802
2024
Q1
$26.6M Buy
178,313
+1,453
+0.8% +$217K 0.01% 1306
2023
Q4
$33.9M Sell
176,860
-39,709
-18% -$7.6M 0.01% 1176
2023
Q3
$38.4M Sell
216,569
-173,558
-44% -$30.7M 0.01% 1064
2023
Q2
$74.1M Buy
390,127
+22,752
+6% +$4.32M 0.02% 810
2023
Q1
$73.6M Sell
367,375
-302,474
-45% -$60.6M 0.02% 812
2022
Q4
$159M Sell
669,849
-67,981
-9% -$16.2M 0.05% 547
2022
Q3
$148M Buy
737,830
+568,999
+337% +$114M 0.05% 521
2022
Q2
$24.6M Sell
168,831
-799,924
-83% -$117M 0.01% 1246
2022
Q1
$158M Buy
968,755
+78,665
+9% +$12.8M 0.04% 586
2021
Q4
$151M Sell
890,090
-164,082
-16% -$27.8M 0.04% 625
2021
Q3
$199M Buy
1,054,172
+52,271
+5% +$9.87M 0.05% 500
2021
Q2
$170M Sell
1,001,901
-214,202
-18% -$36.3M 0.04% 608
2021
Q1
$172M Sell
1,216,103
-62,139
-5% -$8.77M 0.05% 551
2020
Q4
$166M Buy
1,278,242
+183,591
+17% +$23.9M 0.05% 514
2020
Q3
$159M Sell
1,094,651
-30,044
-3% -$4.37M 0.05% 442
2020
Q2
$167M Buy
1,124,695
+385,249
+52% +$57.1M 0.06% 396
2020
Q1
$80.5M Buy
739,446
+161,316
+28% +$17.6M 0.03% 588
2019
Q4
$66.6M Buy
578,130
+34,648
+6% +$3.99M 0.02% 864
2019
Q3
$43.7M Buy
543,482
+46,934
+9% +$3.77M 0.01% 1056
2019
Q2
$36M Buy
496,548
+289,314
+140% +$21M 0.01% 1165
2019
Q1
$19.4M Buy
207,234
+189,786
+1,088% +$17.7M 0.01% 1249
2018
Q4
$1.27M Buy
17,448
+2,940
+20% +$214K ﹤0.01% 2810
2018
Q3
$1.27M Sell
14,508
-118,362
-89% -$10.4M ﹤0.01% 2998
2018
Q2
$13.1M Buy
132,870
+77,140
+138% +$7.6M ﹤0.01% 1505
2018
Q1
$6.64M Sell
55,730
-16,675
-23% -$1.99M ﹤0.01% 1784
2017
Q4
$9.2M Sell
72,405
-8,473
-10% -$1.08M ﹤0.01% 1621
2017
Q3
$9.5M Buy
80,878
+51,678
+177% +$6.07M ﹤0.01% 1596
2017
Q2
$2.33M Sell
29,200
-140,948
-83% -$11.2M ﹤0.01% 2448
2017
Q1
$8.72M Buy
170,148
+14,715
+9% +$754K ﹤0.01% 1627
2016
Q4
$5.82M Buy
155,433
+41,667
+37% +$1.56M ﹤0.01% 1894
2016
Q3
$7.71M Buy
113,766
+101,499
+827% +$6.88M ﹤0.01% 1674
2016
Q2
$681K Sell
12,267
-118,168
-91% -$6.56M ﹤0.01% 3099
2016
Q1
$8.19M Sell
130,435
-267,566
-67% -$16.8M ﹤0.01% 1522
2015
Q4
$37.5M Sell
398,001
-135,504
-25% -$12.8M 0.02% 883
2015
Q3
$42.9M Sell
533,505
-173,966
-25% -$14M 0.02% 811
2015
Q2
$84.8M Buy
707,471
+177,724
+34% +$21.3M 0.03% 574
2015
Q1
$55.3M Buy
529,747
+1,139
+0.2% +$119K 0.02% 760
2014
Q4
$51.3M Buy
528,608
+12,628
+2% +$1.22M 0.02% 788
2014
Q3
$40.3M Buy
515,980
+16,578
+3% +$1.29M 0.02% 895
2014
Q2
$31.5M Buy
+499,402
New +$31.5M 0.01% 1023
2014
Q1
Sell
-381
Closed -$24K 4090
2013
Q4
$24K Sell
381
-56,130
-99% -$3.54M ﹤0.01% 4140
2013
Q3
$3.62M Sell
56,511
-105,677
-65% -$6.76M ﹤0.01% 2143
2013
Q2
$5.03M Buy
+162,188
New +$5.03M ﹤0.01% 1844